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Peptide nucleic acids and analogues of peptide nucleic acids 
are used to form duplex, triplex, and other structures with 
nucleic acids and to modify nucleic acids. The peptide 
nucleic acids and analogues thereof also are used to modu 
late protein activity through, for example, transcription 
arrest, transcription initiation, and site speci?c cleavage of 
nucleic acids. 
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